166 related articles for article (PubMed ID: 29941981)
21. Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.
Shi L; Li S; Maurer K; Zhang Z; Petri M; Sullivan KE
Mol Immunol; 2018 Nov; 103():312-321. PubMed ID: 30352365
[TBL] [Abstract][Full Text] [Related]
22. ADAMDEC1 accelerates GBM progression
Qi H; Wang P; Sun H; Li X; Hao X; Tian W; Yu L; Tang J; Dong J; Wang H
Front Oncol; 2022; 12():945025. PubMed ID: 36172139
[TBL] [Abstract][Full Text] [Related]
23. Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα
Ha SE; Jorgensen BG; Wei L; Jin B; Kim MS; Poudrier SM; Singh R; Bartlett A; Zogg H; Kim S; Baek G; Kurahashi M; Lee MY; Kim YS; Choi SC; Sasse KC; Rubin SJS; Gottfried-Blackmore A; Becker L; Habtezion A; Sanders KM; Ro S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563399
[TBL] [Abstract][Full Text] [Related]
24. EDAC: Epithelial defence against cancer-cell competition between normal and transformed epithelial cells in mammals.
Kajita M; Fujita Y
J Biochem; 2015 Jul; 158(1):15-23. PubMed ID: 25991731
[TBL] [Abstract][Full Text] [Related]
25. The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia.
Kozawa K; Sekai M; Ohba K; Ito S; Sako H; Maruyama T; Kakeno M; Shirai T; Kuromiya K; Kamasaki T; Kohashi K; Tanaka S; Ishikawa S; Sato N; Asano S; Suzuki H; Tanimura N; Mukai Y; Gotoh N; Tanino M; Tanaka S; Natsuga K; Soga T; Nakamura T; Yabuta Y; Saitou M; Ito T; Matsuura K; Tsunoda M; Kikumori T; Iida T; Mizutani Y; Miyai Y; Kaibuchi K; Enomoto A; Fujita Y
Curr Biol; 2021 Jul; 31(14):3086-3097.e7. PubMed ID: 34087104
[TBL] [Abstract][Full Text] [Related]
26. Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation.
O'Shea NR; Chew TS; Dunne J; Marnane R; Nedjat-Shokouhi B; Smith PJ; Bloom SL; Smith AM; Segal AW
J Crohns Colitis; 2016 Dec; 10(12):1417-1427. PubMed ID: 27226416
[TBL] [Abstract][Full Text] [Related]
27. ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.
Lund J; Olsen OH; Sørensen ES; Stennicke HR; Petersen HH; Overgaard MT
J Biol Chem; 2013 Jul; 288(29):21367-21375. PubMed ID: 23754285
[TBL] [Abstract][Full Text] [Related]
28. ADAMDEC1 promotes skin inflammation in rosacea via modulating the polarization of M1 macrophages.
Liu T; Deng Z; Xie H; Chen M; Xu S; Peng Q; Sha K; Xiao W; Zhao Z; Li J
Biochem Biophys Res Commun; 2020 Jan; 521(1):64-71. PubMed ID: 31627897
[TBL] [Abstract][Full Text] [Related]
29. FBP17-mediated finger-like membrane protrusions in cell competition between normal and RasV12-transformed cells.
Kamasaki T; Miyazaki Y; Ishikawa S; Hoshiba K; Kuromiya K; Tanimura N; Mori Y; Tsutsumi M; Nemoto T; Uehara R; Suetsugu S; Itoh T; Fujita Y
iScience; 2021 Sep; 24(9):102994. PubMed ID: 34485872
[TBL] [Abstract][Full Text] [Related]
30. Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
Xu J; Liu L; Zheng X; You C; Li Q
Neurol Res; 2012 Sep; 34(7):701-6. PubMed ID: 22776555
[TBL] [Abstract][Full Text] [Related]
31. Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients.
Chai N; Xie P; Chen H; Li Y; Zhao Y; He J; Zhang H
Ann Transl Med; 2023 Jan; 11(1):14. PubMed ID: 36760254
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.
Lund J; Elimar Bitsch AM; Grønbech Rasch M; Enoksson M; Troeberg L; Nagase H; Loftager M; Overgaard MT; Petersen HH
MAbs; 2018 Jan; 10(1):118-128. PubMed ID: 29185848
[TBL] [Abstract][Full Text] [Related]
33. Cell competition-induced apical elimination of transformed cells, EDAC, orchestrates the cellular homeostasis.
Kon S; Fujita Y
Dev Biol; 2021 Aug; 476():112-116. PubMed ID: 33774012
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cells.
Ito S; Kuromiya K; Sekai M; Sako H; Sai K; Morikawa R; Mukai Y; Ida Y; Anzai M; Ishikawa S; Kozawa K; Shirai T; Tanimura N; Sugie K; Ikenouchi J; Ogawa M; Naguro I; Ichijo H; Fujita Y
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2307118120. PubMed ID: 37844241
[TBL] [Abstract][Full Text] [Related]
35. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12.
Bates EE; Fridman WH; Mueller CG
Immunogenetics; 2002 May; 54(2):96-105. PubMed ID: 12037602
[TBL] [Abstract][Full Text] [Related]
36. EphA2 Drives the Segregation of Ras-Transformed Epithelial Cells from Normal Neighbors.
Porazinski S; de Navascués J; Yako Y; Hill W; Jones MR; Maddison R; Fujita Y; Hogan C
Curr Biol; 2016 Dec; 26(23):3220-3229. PubMed ID: 27839970
[TBL] [Abstract][Full Text] [Related]
37. The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia.
Yamauchi H; Matsumaru T; Morita T; Ishikawa S; Maenaka K; Takigawa I; Semba K; Kon S; Fujita Y
Sci Rep; 2015 Oct; 5():15336. PubMed ID: 26480891
[TBL] [Abstract][Full Text] [Related]
38. Interactions between normal and transformed epithelial cells: Their contributions to tumourigenesis.
Hogan C; Kajita M; Lawrenson K; Fujita Y
Int J Biochem Cell Biol; 2011 Apr; 43(4):496-503. PubMed ID: 21187160
[TBL] [Abstract][Full Text] [Related]
39. Src plays a key role in ADAM28 expression in v-src-transformed epithelial cells and human carcinoma cells.
Abe H; Mochizuki S; Ohara K; Ueno M; Ochiai H; Kitagawa Y; Hino O; Sato H; Okada Y
Am J Pathol; 2013 Nov; 183(5):1667-1678. PubMed ID: 24007880
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the interface between normal and transformed epithelial cells.
Hogan C; Dupré-Crochet S; Norman M; Kajita M; Zimmermann C; Pelling AE; Piddini E; Baena-López LA; Vincent JP; Itoh Y; Hosoya H; Pichaud F; Fujita Y
Nat Cell Biol; 2009 Apr; 11(4):460-7. PubMed ID: 19287376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
